|
The XIENCE V system consists of a cobalt chromium stent with a thin coating
of the drug, everolimus, on its surface. The stent gives support to the artery
while the fluorinated copolymer facilitates the controlled release of
everolimus into the artery wall. The release of drug is intended to limit the
overgrowth of tissue after the stent is implanted. Overgrowth of tissue is
thought to be a major factor in renarrowing of the artery after stenting.
XIENCE V is today’s most implanted drug eluting stent, supported by superior
efficacy and long-term safety data.
For more information about this product, please click on the picture. You
will be redirected to the XIENCE V Web site.
|